Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q59160197
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000046.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q59160197
|
024
|
|
|
‡a
0000-0003-0671-7312
‡2
orcid
|
024
|
|
|
‡a
56042377900
‡2
scopus
|
024
|
|
|
‡a
57192923840
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q59160197
|
100
|
0 |
|
‡a
Yan Wang
‡c
researcher ORCID ID = 0000-0003-0671-7312
‡9
en
|
670
|
|
|
‡a
Author's (+/-)-Lucidumone, a COX-2 Inhibitory Caged Fungal Meroterpenoid from Ganoderma lucidum
|
670
|
|
|
‡a
Author's 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
|
670
|
|
|
‡a
Author's A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity.
|
670
|
|
|
‡a
Author's Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells
|
670
|
|
|
‡a
Author's Antiviral activities of whey proteins
|
670
|
|
|
‡a
Author's Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase
|
670
|
|
|
‡a
Author's Characterization of miR-210 in 3T3-L1 adipogenesis.
|
670
|
|
|
‡a
Author's Differential regulation of lipid metabolism genes in the brain of acetylcholinesterase knockout mice
|
670
|
|
|
‡a
Author's Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening
|
670
|
|
|
‡a
Author's Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes.
|
670
|
|
|
‡a
Author's FRET-based assay using a three-way junction DNA substrate to identify inhibitors of human cytomegalovirus pUL89 endonuclease activity
|
670
|
|
|
‡a
Author's Ganoderma cochlear Metabolites as Probes to Identify a COX-2 Active Site and as in Vitro and in Vivo Anti-Inflammatory Agents
|
670
|
|
|
‡a
Author's Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.
|
670
|
|
|
‡a
Author's Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage
|
670
|
|
|
‡a
Author's Lung tissue distribution of drugs as a key factor for COVID-19 treatment
|
670
|
|
|
‡a
Author's Miltirone Is a Dual Inhibitor of P-Glycoprotein and Cell Growth in Doxorubicin-Resistant HepG2 Cells
|
670
|
|
|
‡a
Author's MiR-25 suppresses 3T3-L1 adipogenesis by directly targeting KLF4 and C/EBPα.
|
670
|
|
|
‡a
Author's Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes
|
670
|
|
|
‡a
Author's Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells
|
670
|
|
|
‡a
Author's Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARγ.
|
670
|
|
|
‡a
Author's Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
|
670
|
|
|
‡a
Author's Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
|
909
|
|
|
‡a
(scopus) 57192923840
‡9
1
|
909
|
|
|
‡a
(scopus) 56042377900
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000306717312
‡9
1
|
919
|
|
|
‡a
bovinelactoferrampinhumanlactoferricinandlactoferrin111inhibitnucleartranslocationofhivintegrase
‡A
Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase
‡9
1
|
919
|
|
|
‡a
differentialregulationoflipidmetabolismgenesinthebrainofacetylcholinesteraseknockoutmice
‡A
Differential regulation of lipid metabolism genes in the brain of acetylcholinesterase knockout mice
‡9
1
|
919
|
|
|
‡a
+lucidumoneacox2inhibitorycagedfungalmeroterpenoidfromganodermalucidum
‡A
(+/-)-Lucidumone, a COX-2 Inhibitory Caged Fungal Meroterpenoid from Ganoderma lucidum
‡9
1
|
919
|
|
|
‡a
ganodermacochlearmetabolitesasprobestoidentifyacox2activesiteandasinvitroandinvivoantiinflammatoryagents
‡A
Ganoderma cochlear Metabolites as Probes to Identify a COX-2 Active Site and as in Vitro and in Vivo Anti-Inflammatory Agents
‡9
1
|
919
|
|
|
‡a
herbalogatoolfortargetbasedidentificationofherbaldrugefficacythroughmoleculardocking
‡A
Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.
‡9
1
|
919
|
|
|
‡a
inhibitionofhumancytomegaloviruspul89terminasesubunitblocksvirusreplicationandgenomecleavage
‡A
Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage
‡9
1
|
919
|
|
|
‡a
discoveryoffdaapproveddrugsasinhibitorsoffattyacidbindingprotein4usingmoleculardockingscreening
‡A
Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening
‡9
1
|
919
|
|
|
‡a
synthesisβcatenintranslocationcapabilityandalpactivationactivityof7hthiazolo124triazin71derivatives
‡A
Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
‡9
1
|
919
|
|
|
‡a
miltironeisadualinhibitorofpglycoproteinandcellgrowthindoxorubicinresistanthepg2cells
‡A
Miltirone Is a Dual Inhibitor of P-Glycoprotein and Cell Growth in Doxorubicin-Resistant HepG2 Cells
‡9
1
|
919
|
|
|
‡a
lungtissuedistributionofdrugsasakeyfactorforcovid19treatment
‡A
Lung tissue distribution of drugs as a key factor for COVID-19 treatment
‡9
1
|
919
|
|
|
‡a
14bis5naphthalen1ylthiophen2ylnaphthaleneasmallmoleculefunctionsasanovelantihiv1inhibitortargetingtheinteractionbetweenintegraseandcellularlensepitheliumderivedgrowthfactor
‡A
1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
‡9
1
|
919
|
|
|
‡a
fluorescencebasedhighthroughputassaytoidentifyinhibitorsoftyrosylproteinsulfotransferaseactivity
‡A
A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity.
‡9
1
|
919
|
|
|
‡a
silibininanovelchemokinereceptortype4antagonistinhibitschemokineligand12inducedmigrationinbreastcancercells
‡A
Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
‡9
1
|
919
|
|
|
‡a
enzymekineticandmoleculardockingstudiesfortheinhibitionsofmiltironeonmajorhumancytochromep450isozymes
‡A
Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes.
‡9
1
|
919
|
|
|
‡a
pimozideanovelfattyacidbindingprotein4inhibitorpromotesadipogenesisof3t3l1cellsbyactivatingpparγ
‡A
Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARγ.
‡9
1
|
919
|
|
|
‡a
overexpressionofcxcr4synergizeswithll37inthemetastasisofbreastcancercells
‡A
Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells
‡9
1
|
919
|
|
|
‡a
moleculardockingandenzymekineticstudiesofdihydrotanshinoneonmetabolismofamodelcyp2d6probesubstrateinhumanlivermicrosomes
‡A
Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes
‡9
1
|
919
|
|
|
‡a
mir25suppresses3t3l1adipogenesisbydirectlytargetingklf4and100ebpα
‡A
MiR-25 suppresses 3T3-L1 adipogenesis by directly targeting KLF4 and C/EBPα.
‡9
1
|
919
|
|
|
‡a
fretbasedassayusinga3wayjunctiondnasubstratetoidentifyinhibitorsofhumancytomegaloviruspul89endonucleaseactivity
‡A
FRET-based assay using a three-way junction DNA substrate to identify inhibitors of human cytomegalovirus pUL89 endonuclease activity
‡9
1
|
919
|
|
|
‡a
characterizationofmir210in3t3l1adipogenesis
‡A
Characterization of miR-210 in 3T3-L1 adipogenesis.
‡9
1
|
919
|
|
|
‡a
antiviralactivitiesofwheyproteins
‡A
Antiviral activities of whey proteins
‡9
1
|
919
|
|
|
‡a
acetylshikoninanovelacheinhibitorinhibitsapoptosisviaupregulationofhemeoxygenase1expressioninshsy5ycells
‡A
Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells
‡9
1
|
996
|
|
|
‡2
ISNI|0000000374399424
|
996
|
|
|
‡2
RERO|A000175164
|
996
|
|
|
‡2
ISNI|0000000048690419
|
996
|
|
|
‡2
LC|no 96004549
|
996
|
|
|
‡2
DNB|1325550272
|
996
|
|
|
‡2
DNB|1293281883
|
996
|
|
|
‡2
LC|no2022095315
|
996
|
|
|
‡2
SUDOC|200242334
|
996
|
|
|
‡2
ISNI|0000000039936261
|
996
|
|
|
‡2
RERO|A000175168
|
996
|
|
|
‡2
PLWABN|9810699370505606
|
996
|
|
|
‡2
LC|n 80114164
|
996
|
|
|
‡2
ISNI|0000000382154013
|
996
|
|
|
‡2
LC|n 88109683
|
996
|
|
|
‡2
PLWABN|9811769723105606
|
996
|
|
|
‡2
ISNI|0000000064086465
|
996
|
|
|
‡2
ISNI|0000000419504938
|
996
|
|
|
‡2
DNB|119901432X
|
996
|
|
|
‡2
SZ|1140651439
|
996
|
|
|
‡2
PLWABN|9811772643705606
|
996
|
|
|
‡2
RERO|A022471671
|
996
|
|
|
‡2
ISNI|0000000044596636
|
996
|
|
|
‡2
CYT|AC000424303
|
996
|
|
|
‡2
DNB|1263239447
|
996
|
|
|
‡2
DNB|1306927129
|
996
|
|
|
‡2
CYT|AC000208961
|
996
|
|
|
‡2
ISNI|0000000067817681
|
996
|
|
|
‡2
SUDOC|122895169
|
996
|
|
|
‡2
SUDOC|197649793
|
996
|
|
|
‡2
DNB|1191854175
|
996
|
|
|
‡2
CYT|AC000642299
|
996
|
|
|
‡2
DNB|115862848X
|
996
|
|
|
‡2
LC|n 2017053987
|
996
|
|
|
‡2
DNB|127129839
|
996
|
|
|
‡2
LC|n 96061111
|
996
|
|
|
‡2
BIBSYS|2009457
|
996
|
|
|
‡2
DNB|1077111002
|
996
|
|
|
‡2
CAOONL|ncf11701070
|
996
|
|
|
‡2
DNB|1319275516
|
996
|
|
|
‡2
DNB|1065256744
|
996
|
|
|
‡2
CYT|AC000653596
|
996
|
|
|
‡2
BNF|13741722
|
996
|
|
|
‡2
LC|no2023033414
|
996
|
|
|
‡2
ISNI|0000000493981273
|
996
|
|
|
‡2
CYT|AC000639427
|
996
|
|
|
‡2
DNB|1295769077
|
996
|
|
|
‡2
DNB|1349659134
|
996
|
|
|
‡2
NDL|00891034
|
996
|
|
|
‡2
LIH|LNB:C30_i_;=BF
|
996
|
|
|
‡2
LC|no2007076514
|
996
|
|
|
‡2
LNB|LNC10-000119538
|
996
|
|
|
‡2
CYT|AC000642083
|
996
|
|
|
‡2
LC|n 88648589
|
996
|
|
|
‡2
DNB|1345110839
|
996
|
|
|
‡2
DNB|1213268974
|
996
|
|
|
‡2
J9U|987007463401205171
|
996
|
|
|
‡2
DNB|1135745994
|
996
|
|
|
‡2
LC|n 2014052688
|
996
|
|
|
‡2
LC|nr 99008876
|
996
|
|
|
‡2
CYT|AC000642150
|
996
|
|
|
‡2
CAOONL|ncf11934366
|
996
|
|
|
‡2
NSK|000192927
|
996
|
|
|
‡2
LC|n 2019051852
|
996
|
|
|
‡2
DNB|1075496675
|
996
|
|
|
‡2
SUDOC|184302951
|
996
|
|
|
‡2
BIBSYS|90059378
|
996
|
|
|
‡2
CYT|AC000642409
|
996
|
|
|
‡2
LC|no2021056836
|
996
|
|
|
‡2
DNB|1144302137
|
996
|
|
|
‡2
LC|nb2022013180
|
996
|
|
|
‡2
CYT|AC000636631
|
996
|
|
|
‡2
LC|no2022142256
|
996
|
|
|
‡2
NUKAT|n 2016006108
|
996
|
|
|
‡2
CYT|AC000046456
|
996
|
|
|
‡2
ISNI|0000000454529524
|
996
|
|
|
‡2
CYT|AC000099163
|
996
|
|
|
‡2
DNB|1190738546
|
996
|
|
|
‡2
DNB|101303029X
|
996
|
|
|
‡2
BNF|15067230
|
996
|
|
|
‡2
DNB|1262029538
|
996
|
|
|
‡2
ISNI|0000000107188681
|
996
|
|
|
‡2
CYT|AC000400491
|
996
|
|
|
‡2
CYT|AC000400493
|
996
|
|
|
‡2
DNB|1186759054
|
996
|
|
|
‡2
BIBSYS|2075601
|
996
|
|
|
‡2
BNF|16264077
|
996
|
|
|
‡2
NTA|095885919
|
996
|
|
|
‡2
DNB|133071138
|
996
|
|
|
‡2
DNB|1296592499
|
996
|
|
|
‡2
NSK|000461453
|
996
|
|
|
‡2
NTA|114973296
|
996
|
|
|
‡2
DNB|1161745556
|
996
|
|
|
‡2
CYT|AC000577822
|
996
|
|
|
‡2
CYT|AC000642464
|
996
|
|
|
‡2
NSK|000574095
|
996
|
|
|
‡2
ISNI|0000000051083193
|
996
|
|
|
‡2
SUDOC|176232397
|
996
|
|
|
‡2
CYT|AC000633687
|
996
|
|
|
‡2
ISNI|0000000083148027
|
996
|
|
|
‡2
DNB|1046472542
|
996
|
|
|
‡2
CYT|AC000659360
|
996
|
|
|
‡2
DNB|1089621434
|
996
|
|
|
‡2
LC|no2008073645
|
996
|
|
|
‡2
DNB|1237003016
|
996
|
|
|
‡2
DNB|1141394197
|
996
|
|
|
‡2
NUKAT|n 2011112672
|
996
|
|
|
‡2
DBC|87097969074782
|
996
|
|
|
‡2
CAOONL|ncf10723261
|
996
|
|
|
‡2
LC|nr 95016275
|
996
|
|
|
‡2
CYT|AC000632624
|
996
|
|
|
‡2
ISNI|0000000444584167
|
996
|
|
|
‡2
ISNI|0000000071508312
|
996
|
|
|
‡2
LIH|LNB:_g_E_q_;=B_t_
|
996
|
|
|
‡2
CYT|AC000451516
|
996
|
|
|
‡2
ISNI|0000000126262883
|
996
|
|
|
‡2
NUKAT|n 2016156112
|
996
|
|
|
‡2
DNB|1197420614
|
996
|
|
|
‡2
ISNI|000000037789501X
|
996
|
|
|
‡2
J9U|987007370953405171
|
996
|
|
|
‡2
ISNI|0000000383112421
|
996
|
|
|
‡2
NTA|227477030
|
996
|
|
|
‡2
DNB|1231239352
|
996
|
|
|
‡2
PLWABN|9811771554805606
|
996
|
|
|
‡2
DNB|1081841060
|
996
|
|
|
‡2
NTA|438699432
|
996
|
|
|
‡2
NDL|00346721
|
996
|
|
|
‡2
DNB|1059125005
|
996
|
|
|
‡2
DNB|123823609X
|
996
|
|
|
‡2
DNB|1162524022
|
996
|
|
|
‡2
SUDOC|250833409
|
996
|
|
|
‡2
LC|no2015086068
|
996
|
|
|
‡2
SUDOC|030260310
|
996
|
|
|
‡2
LC|no2006029710
|
996
|
|
|
‡2
CYT|AC000540917
|
996
|
|
|
‡2
LC|n 2019005326
|
996
|
|
|
‡2
RERO|A027169319
|
996
|
|
|
‡2
DNB|1338182404
|
996
|
|
|
‡2
LC|n 91026181
|
996
|
|
|
‡2
LC|n 2016181547
|
996
|
|
|
‡2
LC|no2018043014
|
996
|
|
|
‡2
DNB|1178378187
|
996
|
|
|
‡2
NUKAT|n 2021123640
|
996
|
|
|
‡2
DNB|1318496829
|
996
|
|
|
‡2
DNB|170718026
|
996
|
|
|
‡2
BIBSYS|8067012
|
996
|
|
|
‡2
LC|n 88031425
|
996
|
|
|
‡2
PLWABN|9810596153905606
|
996
|
|
|
‡2
ISNI|0000000457685290
|
996
|
|
|
‡2
LC|n 2013030029
|
996
|
|
|
‡2
CAOONL|ncf11934459
|
996
|
|
|
‡2
DNB|1187976628
|
996
|
|
|
‡2
CYT|AC000639520
|
996
|
|
|
‡2
LC|no 89012091
|
996
|
|
|
‡2
CYT|AC000642355
|
996
|
|
|
‡2
NII|DA09136850
|
996
|
|
|
‡2
CYT|AC000118449
|
996
|
|
|
‡2
LC|n 2015183216
|
996
|
|
|
‡2
DNB|1175901962
|
996
|
|
|
‡2
ISNI|0000000050680391
|
996
|
|
|
‡2
CAOONL|ncf11049826
|
996
|
|
|
‡2
ISNI|0000000509753292
|
996
|
|
|
‡2
SUDOC|277062950
|
996
|
|
|
‡2
DNB|1103458213
|
996
|
|
|
‡2
NUKAT|n 01107351
|
996
|
|
|
‡2
RERO|A022000557
|
996
|
|
|
‡2
LC|no2013080018
|
996
|
|
|
‡2
CYT|AC000007788
|
996
|
|
|
‡2
CYT|AC000210705
|
996
|
|
|
‡2
CYT|AC000210702
|
996
|
|
|
‡2
NKC|xx0256372
|
996
|
|
|
‡2
NSK|000434521
|
996
|
|
|
‡2
DNB|1102201952
|
996
|
|
|
‡2
BNC|981060788470406706
|
996
|
|
|
‡2
LC|n 2016026553
|
996
|
|
|
‡2
LC|n 2018005562
|
996
|
|
|
‡2
CYT|AC000000235
|
996
|
|
|
‡2
DNB|1337309036
|
996
|
|
|
‡2
DNB|1073882454
|
996
|
|
|
‡2
ISNI|0000000108178215
|
996
|
|
|
‡2
SUDOC|264387104
|
996
|
|
|
‡2
LC|no2023071375
|
996
|
|
|
‡2
CYT|AC000652939
|
996
|
|
|
‡2
PLWABN|9811493035905606
|
996
|
|
|
‡2
SZ|1243760400
|
996
|
|
|
‡2
DNB|1133094155
|
996
|
|
|
‡2
DNB|1077373392
|
996
|
|
|
‡2
BNF|17907041
|
996
|
|
|
‡2
ISNI|0000000436239208
|
996
|
|
|
‡2
LC|n 2022054139
|
996
|
|
|
‡2
DNB|122816410X
|
996
|
|
|
‡2
ISNI|0000000403177370
|
996
|
|
|
‡2
DNB|1051583063
|
996
|
|
|
‡2
DNB|1282769766
|
996
|
|
|
‡2
ISNI|0000000063984781
|
996
|
|
|
‡2
CAOONL|ncf12068028
|
996
|
|
|
‡2
LC|nr 92020469
|
996
|
|
|
‡2
PLWABN|9811569676005606
|
996
|
|
|
‡2
PLWABN|9811537004205606
|
996
|
|
|
‡2
DNB|1344528562
|
996
|
|
|
‡2
LC|no2021029733
|
996
|
|
|
‡2
DNB|1270733958
|
996
|
|
|
‡2
SUDOC|272984671
|
996
|
|
|
‡2
ISNI|0000000495823498
|
996
|
|
|
‡2
LC|n 2018050306
|
996
|
|
|
‡2
LC|n 2013180463
|
996
|
|
|
‡2
NTA|340415975
|
996
|
|
|
‡2
SUDOC|158240251
|
996
|
|
|
‡2
NUKAT|n 2021211886
|
996
|
|
|
‡2
NTA|355347261
|
996
|
|
|
‡2
NKC|xx0243033
|
996
|
|
|
‡2
ISNI|0000000363101880
|
996
|
|
|
‡2
NSK|000649310
|
996
|
|
|
‡2
CYT|AC000400128
|
996
|
|
|
‡2
LC|n 2019022257
|
996
|
|
|
‡2
ISNI|000000035606935X
|
996
|
|
|
‡2
NKC|jx20130128008
|
996
|
|
|
‡2
NSK|000690445
|
996
|
|
|
‡2
ISNI|0000000115173703
|
996
|
|
|
‡2
ISNI|0000000081145367
|
996
|
|
|
‡2
ISNI|0000000383138330
|
996
|
|
|
‡2
DNB|1042697817
|
996
|
|
|
‡2
DNB|1034067249
|
996
|
|
|
‡2
LC|nr 91016566
|
996
|
|
|
‡2
LC|n 2001088517
|
996
|
|
|
‡2
ISNI|0000000425056166
|
996
|
|
|
‡2
DNB|1017027439
|
996
|
|
|
‡2
LC|no2022000061
|
996
|
|
|
‡2
LC|n 87939287
|
996
|
|
|
‡2
SUDOC|200707043
|
996
|
|
|
‡2
LC|no2015163753
|
996
|
|
|
‡2
NDL|00481893
|
996
|
|
|
‡2
LC|no2022132584
|
996
|
|
|
‡2
NTA|408560118
|
996
|
|
|
‡2
BIBSYS|90573655
|
996
|
|
|
‡2
ISNI|0000000124205068
|
996
|
|
|
‡2
SUDOC|177468106
|
996
|
|
|
‡2
DNB|1011430061
|
996
|
|
|
‡2
LC|n 2018014479
|
996
|
|
|
‡2
NTA|140089284
|
996
|
|
|
‡2
CYT|AC000652892
|
996
|
|
|
‡2
DNB|1169260497
|
996
|
|
|
‡2
ISNI|0000000108828636
|
996
|
|
|
‡2
J9U|987007380291505171
|
996
|
|
|
‡2
CAOONL|ncf10244421
|
996
|
|
|
‡2
SIMACOB|276840291
|
996
|
|
|
‡2
LC|no2016134271
|
996
|
|
|
‡2
ISNI|0000000084458377
|
996
|
|
|
‡2
DNB|1172300240
|
996
|
|
|
‡2
DNB|1212146999
|
996
|
|
|
‡2
BNF|16251369
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|